These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 26703528)

  • 1. Understanding Critical Quality Attributes for Nanocrystals from Preparation to Delivery.
    Peltonen L; Strachan C
    Molecules; 2015 Dec; 20(12):22286-300. PubMed ID: 26703528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug nanocrystals - Versatile option for formulation of poorly soluble materials.
    Peltonen L; Hirvonen J
    Int J Pharm; 2018 Feb; 537(1-2):73-83. PubMed ID: 29262301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State of the Art of Pharmaceutical Solid Forms: from Crystal Property Issues to Nanocrystals Formulation.
    Couillaud BM; Espeau P; Mignet N; Corvis Y
    ChemMedChem; 2019 Jan; 14(1):8-23. PubMed ID: 30457705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vivo fate of nanocrystals.
    Lu Y; Qi J; Dong X; Zhao W; Wu W
    Drug Discov Today; 2017 Apr; 22(4):744-750. PubMed ID: 28088442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical nanocrystals: production by wet milling and applications.
    Malamatari M; Taylor KMG; Malamataris S; Douroumis D; Kachrimanis K
    Drug Discov Today; 2018 Mar; 23(3):534-547. PubMed ID: 29326082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanosizing techniques for improving bioavailability of drugs.
    Al-Kassas R; Bansal M; Shaw J
    J Control Release; 2017 Aug; 260():202-212. PubMed ID: 28603030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Spray-Dried Dispersions in Early Pharmaceutical Development: Theoretical and Practical Challenges.
    Li J; Patel D; Wang G
    AAPS J; 2017 Mar; 19(2):321-333. PubMed ID: 27896684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical Strategies for Stabilizing Drug Nanocrystals.
    Yang H; Kim H; Jung S; Seo H; Nida SK; Yoo SY; Lee J
    Curr Pharm Des; 2018; 24(21):2362-2374. PubMed ID: 29766785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in the study of drug nanocrystals.
    Shi J; Guo F; Zheng A; Zhang X; Sun J
    Pharmazie; 2015 Dec; 70(12):757-64. PubMed ID: 26817271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in the development of stabilization strategies for nanocrystal preparations.
    Li J; Wang Z; Zhang H; Gao J; Zheng A
    Drug Deliv; 2021 Dec; 28(1):19-36. PubMed ID: 33336609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size.
    Sinha B; Müller RH; Möschwitzer JP
    Int J Pharm; 2013 Aug; 453(1):126-41. PubMed ID: 23333709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanocrystal Based Drug Delivery System: Conventional and Current Scenario.
    Thakkar S; Shah V; Misra M; Kalia K
    Recent Pat Nanotechnol; 2017 Jul; 11(2):130-145. PubMed ID: 27758683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A top-down technique to improve the solubility and bioavailability of aceclofenac: in vitro and in vivo studies.
    Narayan R; Pednekar A; Bhuyan D; Gowda C; Koteshwara KB; Nayak UY
    Int J Nanomedicine; 2017; 12():4921-4935. PubMed ID: 28744125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into the mechanism behind oral bioavailability-enhancement by nanosuspensions through combined dissolution/permeation studies.
    Lynnerup JT; Eriksen JB; Bauer-Brandl A; Holsæter AM; Brandl M
    Eur J Pharm Sci; 2023 May; 184():106417. PubMed ID: 36870578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in the use of nanocrystals to improve bioavailability of APIs.
    Ding Y; Zhao T; Fang J; Song J; Dong H; Liu J; Li S; Zhao M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1958. PubMed ID: 38629192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopharmaceutical aspects and implications of excipient variability in drug product performance.
    Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
    Eur J Pharm Biopharm; 2017 Feb; 111():1-15. PubMed ID: 27845182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesoporous systems for poorly soluble drugs - recent trends.
    Riikonen J; Xu W; Lehto VP
    Int J Pharm; 2018 Jan; 536(1):178-186. PubMed ID: 29183856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced oral bioavailability of glycyrrhetinic acid via nanocrystal formulation.
    Lei Y; Kong Y; Sui H; Feng J; Zhu R; Wang W
    Drug Deliv Transl Res; 2016 Oct; 6(5):519-25. PubMed ID: 27206446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellulose nanofibers as excipient for the delivery of poorly soluble drugs.
    Löbmann K; Svagan AJ
    Int J Pharm; 2017 Nov; 533(1):285-297. PubMed ID: 28951349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution enhancement and in vitro performance of clarithromycin nanocrystals produced by precipitation-lyophilization-homogenization method.
    Morakul B; Suksiriworapong J; Chomnawang MT; Langguth P; Junyaprasert VB
    Eur J Pharm Biopharm; 2014 Nov; 88(3):886-96. PubMed ID: 25201298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.